Wed. 19 Sep 2018, 10:49 am

Australian NSP Survey National Data Report 2013-2017


  • Author

    Insight

  • Categories

    injecting

UNSW's Kirby Institute have recently released a 5-year report from their Australian Needle and Syringe Program Survey (ANSPS), which provides estimates of HIV and Hep C prevalence and sexual and injecting risk behaviour among people who inject drugs in Australia.
Key findings include:
  • In 2017, 52 Australian Needle and Syringe Programs (NSPs) participated in the ANSPS and 2,600 NSP attendees completed the survey. The response rate was 41%.
  • Over the period 2013 to 2017, the median age of survey respondents increased from 39 years to 42 years, with a concurrent decrease in the proportion of young injectors (aged <25 years) from 8% in 2013 to 5% in 2017.
  • HIV antibody prevalence remained low and stable nationally, ranging from 1.4% to 2.1% over the period 2013 to 2017.
  • Hepatitis C virus antibody prevalence declined from 54% in 2013 to 49% in 2017.
  • Nationally, the proportion of respondents who reported recent (last 12 months) initiation of HCV treatment was low and stable at 1-3% between 2011-2015, but increased significantly to 22% in 2016 and 36% in 2017, with substantial increases observed in all jurisdictions
Go to the 2018 NSP Survey Report

Other news

Stay
informed

Subscribe for the latest news, updates, information and resources from the alcohol and drug sector in Queensland and beyond.